Publications by authors named "Donald W Combs"

Claim this Profile
P
Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase.
Khehyong Ngu, David S Weinstein, Wen Liu, Charles Langevine, Donald W Combs

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment.
David S Weinstein, Wen Liu, Khehyong Ngu, Charles Langevine, Donald W Combs

Bioorg Med Chem Lett· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.
David S Weinstein, Wen Liu, Zhengxiang Gu, Charles Langevine, Khehyong Ngu, Donald W Combs

Bioorg Med Chem Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of spirobenzazepines as potent vasopressin receptor antagonists.
Min Amy Xiang, Robert H Chen, Keith T Demarest, Joseph Gunnet, Richard Look, Donald W Combs

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of nonpeptide substituted spirobenzazepines as potent vasopressin antagonists.
Min Amy Xiang, Robert H Chen, Keith T Demarest, Joseph Gunnet, Richard Look, Donald W Combs

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminoimidazoles as bioisosteres of acylguanidines: novel, potent, selective and orally bioavailable inhibitors of the sodium hydrogen exchanger isoform-1.
Saleem Ahmad, Khehyong Ngu, Donald W Combs, Shung C Wu, David S Weinstein

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzoxazinones as PPARgamma agonists. 2. SAR of the amide substituent and in vivo results in a type 2 diabetes model.
Philip J Rybczynski, Roxanne E Zeck, Joseph Dudash, Donald W Combs, Thomas P Burris

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regions.
Philip J Rybczynski, Roxanne E Zeck, Donald W Combs, Ignatius Turchi, Thomas P Burris

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis